FDA Grants Emergency Use Authorization to CRISPR High Throughput COVID-19 Test

Article

The kit helps detect SARS-CoV-2 RNA in nasopharyngeal, anterior nasal, mid-turbinate nasal or oropharyngeal swab specimens from individuals suspected of COVID-19 by their health care provider.

The FDA has granted Emergency Use Authorization (EUA) to Mammoth Biosciences, Inc, for its DETECTR BOOST SARS-CoV-2 Reagent Kit, which combines CRISPR technology with laboratory automation for SARS-CoV-2 testing.

The platform is a CRISPR-based molecular diagnostic system that enables high-throughput, sample-to-answer testing with PCR-equivalent performance and minimal hands-on-time. The kit helps detect SARS-CoV-2 RNA in nasopharyngeal, anterior nasal, mid-turbinate nasal or oropharyngeal swab specimens from individuals suspected of COVID-19 by their health care provider.

“Mammoth’s DETECTR BOOST SARS-CoV-2 assay rivals best-in-class PCR performance and this emergency use authorization is another important step towards our mission to harness the full potential of CRISPR to improve lives,” said Janice Chen, PhD, co-founder and CTO of Mammoth Biosciences, in a press release. “We are proud of the team, our partners and sponsors for their commitment to developing novel testing solutions to address the COVID-19 pandemic.”

The DETECTR BOOST SARS-CoV-2 Reagent Kit has not been FDA cleared or approved, and the project is supported by the National Institutes of Health Rapid Acceleration of Diagnostics program in part with the National Institute of Biomedical Imaging and Bioengineering.

REFERENCE

Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test. BusinessWire. January 24, 2022. Accessed January 25, 2022. https://www.businesswire.com/news/home/20220124005618/en

Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
palliative and hospice care/ Image Credits: © David Pereiras - stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.